Telix is a biopharmaceutical company focused on the development and commercialisation of diagnostic and therapeutic ('theranostic') radiopharmaceuticals. Telix is headquartered in Melbourne, Australia with commercial operations in the United States, Europe (Belgium and Switzerland) and Japan. Telix is developing a portfolio of radiopharmaceutical products that aims to address significant unmet medical need in oncology and rare diseases. Telix is listed on the Australian Securities Exchange (ASX: TLX).
View Top Employees from Telix Pharmaceuticals LimitedWebsite | http://www.telixpharma.com |
Ticker | TLX |
Revenue | $137000 |
Employees | 372 (299 on RocketReach) |
Founded | 2015 |
Address | 55 Flemington Rd, North Melbourne, Victoria 3051, AU |
Phone | +61 449 148 448 |
Technologies |
JavaScript,
HTML,
Twitter
+18 more
(view full list)
|
Industry | Biotechnology Research, Pharmaceuticals, Healthcare |
Keywords | Nuclear Medicine, Precision Medicine |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 62151 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 621 Companies, NAICS Code 32 Companies, NAICS Code 6215 Companies, NAICS Code 62 Companies, NAICS Code 32541 Companies |
Looking for a particular Telix Pharmaceuticals Limited employee's phone or email?
The Telix Pharmaceuticals Limited annual revenue was $137000 in 2024.
299 people are employed at Telix Pharmaceuticals Limited.
Telix Pharmaceuticals Limited is based in North Melbourne, Victoria.
The NAICS codes for Telix Pharmaceuticals Limited are [62151, 3254, 325, 621, 32, 6215, 62, 32541].
The SIC codes for Telix Pharmaceuticals Limited are [283, 28].